165 related articles for article (PubMed ID: 14568947)
1. M cell DNA vaccination for CTL immunity to HIV.
Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
[TBL] [Abstract][Full Text] [Related]
2. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
Belyakov IM; Moss B; Strober W; Berzofsky JA
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4512-7. PubMed ID: 10200293
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
Belyakov IM; Derby MA; Ahlers JD; Kelsall BL; Earl P; Moss B; Strober W; Berzofsky JA
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1709-14. PubMed ID: 9465081
[TBL] [Abstract][Full Text] [Related]
5. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
Xi Y; Day SL; Jackson RJ; Ranasinghe C
Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
Shata MT; Hone DM
J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
[TBL] [Abstract][Full Text] [Related]
7. Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein.
Wierzbicki A; Kiszka I; Kaneko H; Kmieciak D; Wasik TJ; Gzyl J; Kaneko Y; Kozbor D
Vaccine; 2002 Jan; 20(9-10):1295-307. PubMed ID: 11818148
[TBL] [Abstract][Full Text] [Related]
8. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV env immunities elicited by nucleic acid vaccines.
Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
[TBL] [Abstract][Full Text] [Related]
10. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
Allen TM; Vogel TU; Fuller DH; Mothé BR; Steffen S; Boyson JE; Shipley T; Fuller J; Hanke T; Sette A; Altman JD; Moss B; McMichael AJ; Watkins DI
J Immunol; 2000 May; 164(9):4968-78. PubMed ID: 10779808
[TBL] [Abstract][Full Text] [Related]
11. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
[TBL] [Abstract][Full Text] [Related]
12. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.
Belyakov IM; Ahlers JD; Clements JD; Strober W; Berzofsky JA
J Immunol; 2000 Dec; 165(11):6454-62. PubMed ID: 11086085
[TBL] [Abstract][Full Text] [Related]
13. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.
Corbet S; Vinner L; Hougaard DM; Bryder K; Nielsen HV; Nielsen C; Fomsgaard A
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1997-2008. PubMed ID: 11153083
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
Horner AA; Datta SK; Takabayashi K; Belyakov IM; Hayashi T; Cinman N; Nguyen MD; Van Uden JH; Berzofsky JA; Richman DD; Raz E
J Immunol; 2001 Aug; 167(3):1584-91. PubMed ID: 11466380
[TBL] [Abstract][Full Text] [Related]
15. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Calarota SA; Kjerrström A; Islam KB; Wahren B
Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
[TBL] [Abstract][Full Text] [Related]
16. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
17. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
Tobery TW; Siliciano RF
J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus.
Fomsgaard A; Nielsen HV; Nielsen C; Johansson K; Machuca R; Bruun L; Hansen J; Buus S
APMIS; 1998 Jun; 106(6):636-46. PubMed ID: 9725796
[TBL] [Abstract][Full Text] [Related]
19. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
Perales MA; Schwartz DH; Fabry JA; Lieberman J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
[TBL] [Abstract][Full Text] [Related]
20. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]